You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

How often do lurbinectedin side effects occur?

See the DrugPatentWatch profile for lurbinectedin

Lurbinectedin is a medication used to treat certain types of cancer. As with any drug, it can cause side effects. However, the frequency of these side effects can vary.

According to the drug's prescribing information, common side effects of lurbinectedin include fatigue, nausea, vomiting, constipation, and decreased appetite. These side effects occur in more than 25% of patients treated with the drug [1].

Less common side effects, which occur in 10-25% of patients, include abdominal pain, diarrhea, fever, and increased liver enzymes [1].

Rare side effects, which occur in less than 10% of patients, include peripheral neuropathy, dehydration, and electrolyte imbalances [1].

It is important to note that not all patients will experience side effects, and some may experience side effects not listed here. Additionally, the frequency and severity of side effects can vary depending on a number of factors, including the dose of the drug, the patient's overall health, and other medications the patient is taking.

If you are taking lurbinectedin and experience any side effects, it is important to report them to your healthcare provider. They can help you manage the side effects and determine whether you should continue taking the medication.

Sources:
[1] Lurbinectedin (Zepzelca) prescribing information. <https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214437s000lbl.pdf>


Other Questions About Lurbinectedin :  How does lurbinectedin s effectiveness compare to standard chemo? Can lurbinectedin be stored in a freezer? Has lurbinectedin been tested with other drugs?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved. Privacy